Literature DB >> 28417882

EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.

Julia Wendon,, Juan Cordoba, Anil Dhawan, Fin Stolze Larsen, Michael Manns, Didier Samuel, Kenneth J Simpson, Ilan Yaron, Mauro Bernardi.   

Abstract

The term acute liver failure (ALF) is frequently applied as a generic expression to describe patients presenting with or developing an acute episode of liver dysfunction. In the context of hepatological practice, however, ALF refers to a highly specific and rare syndrome, characterised by an acute abnormality of liver blood tests in an individual without underlying chronic liver disease. The disease process is associated with development of a coagulopathy of liver aetiology, and clinically apparent altered level of consciousness due to hepatic encephalopathy. Several important measures are immediately necessary when the patient presents for medical attention. These, as well as additional clinical procedures will be the subject of these clinical practice guidelines.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28417882     DOI: 10.1016/j.jhep.2016.12.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  128 in total

1.  Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females.

Authors:  Kathryn Clarkston; Joy Lee; Sarah Donoghue; Heidi Peters; Hernan Eiroa; Amit A Shah; Kathleen Loomes; Jessica Wen; Mark Oliver; Winita Hardikar; Carlos E Prada; Akihiro Asai
Journal:  Am J Med Genet A       Date:  2020-12-24       Impact factor: 2.802

Review 2.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

Review 4.  Fibroblast growth factors 19 and 21 in acute liver damage.

Authors:  Zhao Shan; Gloria Alvarez-Sola; Iker Uriarte; María Arechederra; Maite G Fernández-Barrena; Carmen Berasain; Cynthia Ju; Matías A Avila
Journal:  Ann Transl Med       Date:  2018-06

Review 5.  [Hepatic dysfunction in patients with cardiogenic shock].

Authors:  Philipp Kasper; Frank Tacke; Hans-Michael Steffen; Guido Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-09-19       Impact factor: 0.840

Review 6.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

7.  The persistent potential of extracorporeal therapies in liver failure.

Authors:  Valentin Fuhrmann; Michael Bauer; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2019-12-10       Impact factor: 17.440

Review 8.  Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease.

Authors:  Afif Yaccob; Amir Mari
Journal:  Frontline Gastroenterol       Date:  2018-10-09

9.  Acute liver failure.

Authors:  Mohammed A Arshad; Nicholas Murphy; Mansoor N Bangash
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

Review 10.  Acute Fatty Liver of Pregnancy: Pathophysiology, Anesthetic Implications, and Obstetrical Management.

Authors:  Emily E Naoum; Lisa R Leffert; Hovig V Chitilian; Kathryn J Gray; Brian T Bateman
Journal:  Anesthesiology       Date:  2019-03       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.